The pancreatic cancer microenvironment: A true double agent

Area of Science:

• Oncology
• Cancer Biology
• Tumor Microenvironment Research

Background:

• Pancreatic cancer is characterized by a dense, immunosuppressive tumor microenvironment (TME).
• This TME includes extracellular matrix, immune cells, growth factors, and pancreatic stellate cells (PSCs), also known as cancer-associated fibroblasts (CAFs).
• The complex interplay of these components promotes tumor growth and resistance to therapy.

Purpose of the Study:

• To review the multifaceted nature of the pancreatic cancer tumor microenvironment.
• To identify and discuss key molecular targets within the TME.
• To provide an overview of developing clinical therapeutics targeting these components.

Main Methods:

• Literature review of pancreatic cancer TME research.
• Analysis of key molecular targets and signaling pathways.
• Survey of current and emerging clinical therapeutic strategies.

Main Results:

• The TME comprises numerous pro- and anti-tumorigenic elements, including hyaluronan, angiogenesis factors, focal adhesion kinase (FAK), connective tissue growth factor (CTGF), CD40, CXCR-4, and Vitamin D.
• Pancreatic stellate cells (PSCs) are crucial components of the desmoplastic stroma.
• Various therapeutic strategies are under investigation to modulate the TME.

Conclusions:

• Targeting the complex pancreatic cancer TME is essential for therapeutic advancement.
• Modulating components like CAFs, immune cells, and specific molecular pathways holds promise.
• Further clinical development of novel therapeutics is critical for improving patient outcomes.